MétaCan
Menu
Back to cohort
Record W2056893663 · doi:10.1093/jnci/djv036

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

2015· article· en· W2056893663 on OpenAlexafffund
Nasim Mavaddat, Paul D.P. Pharoah, Kyriaki Michailidou, Jonathan P. Tyrer, Mark N. Brook, Manjeet K. Bolla, Qin Wang, Joe Dennis, Alison M. Dunning, Mitul Shah, Robert Luben, Judith Brown, Stig E. Bojesen, Børge G. Nordestgaard, Sune F. Nielsen, Henrik Flyger, Kamila Czene, Hatef Darabi, Mikael Eriksson, Julian Peto, Isabel dos‐Santos‐Silva, Frank Dudbridge, Nichola Johnson, Marjanka K. Schmidt, Annegien Broeks, Senno Verhoef, Emiel J. Rutgers, Anthony J. Swerdlow, Alan Ashworth, Nick Orr, Minouk J. Schoemaker, Jonine D. Figueroa, Stephen J. Chanock, Louise A. Brinton, Jolanta Lissowska, Fergus J. Couch, Janet E. Olson, Celine M. Vachon, V. Shane Pankratz, Diether Lambrechts, Hans Wildiers, Chantal Van Ongeval, Erik Van Limbergen, Vessela Kristensen, Grethe Grenaker Alnæs, Silje Nord, Anne‐Lise Børresen‐Dale, Heli Nevanlinna, Taru Muranen, Kristiina Aittomäki, Carl Blomqvist, Jenny Chang‐Claude, Anja Rudolph, Petra Seibold, Dieter Flesch‐Janys, Peter A. Fasching, Lothar Haeberle, Arif B. Ekici, Matthias W. Beckmann, Barbara Burwinkel, Frederik Marmé, Andreas Schneeweiß, Christof Sohn, Amy Trentham‐Dietz, Polly A. Newcomb, Linda Titus, Kathleen M. Egan, David J. Hunter, Sara Lindström, Rulla M. Tamimi, Peter Kraft, Nazneen Rahman, Clare Turnbull, Anthony Renwick, Sheila Seal, Jingmei Li, Jianjun Liu, Keith Humphreys, Javier Benı́tez, M. Pilar Zamora, José Ignacio Arias Pérez, Primitiva Menéndez, Anna Jakubowska, Jan Lubiński, Katarzyna Jaworska–Bieniek, Katarzyna Durda, Natalia Bogdanova, Natalia Antonenkova, Thilo Dörk, Hoda Anton‐Culver, Susan L. Neuhausen, Argyrios Ziogas, Leslie Bernstein, Peter Devilee, Robert A.E.M. Tollenaar, Caroline Seynaeve, Christi J. van Asperen, Angela Cox, Simon S. Cross, Malcolm Reed, Э. К. Хуснутдинова, Marina Bermisheva, Darya Prokofyeva, Zalina Takhirova, Alfons Meindl, Rita K. Schmutzler, Christian Sutter, Rongxi Yang, Peter Schürmann, Michael Bremer, Hans Christiansen, Tjoung‐Won Park‐Simon, Peter Hillemanns, Pascal Guénel, Thérèse Truong, F. Ménégaux, Paolo Radice, Paolo Peterlongo, Siranoush Manoukian, Valeria Pensotti, John L. Hopper, Helen Tsimiklis, Carmel Apicella, Melissa C. Southey, Hiltrud Brauch, Thomas Brüning, Yon‐Dschun Ko, Alice J. Sigurdson, Michele M. Doody, Ute Hamann, Diana Torres, Hans-Ulrich Ulmer, Asta Försti, Elinor J. Sawyer, Ian Tomlinson, Michael J. Kerin, Nicola Miller, Irene L. Andrulis, Julia A. Knight, Gord Glendon, Anna Marie Mulligan, Georgia Chenevix‐Trench, Rosemary L. Balleine, Graham G. Giles, Roger L. Milne, Catriona McLean, Annika Lindblom, Sara Margolin, Christopher A. Haiman, Brian E. Henderson, Fredrick R. Schumacher, Loı̈c Le Marchand, Ursula Eilber, Shan Wang‐Gohrke, Maartje J. Hooning, Antoinette Hollestelle, Ans M.W. van den Ouweland, Linetta B. Koppert, Jane Carpenter, Christine L. Clarke, Rodney J. Scott, Vesa Kataja, Veli-Matti Kosma, Jaana M. Hartikainen, Hermann Brenner, Volker Arndt, Christa Stegmaier, Aida Karina Dieffenbach, Robert Winqvist, Katri Pylkäs, Arja Jukkola‐Vuorinen, Mervi Grip, Kenneth Offit, Joseph Vijai, Mark E. Robson, Rohini Rau‐Murthy, Miriam Dwek, Ruth Swann, Katherine Annie Perkins, Mark S. Goldberg, France Labrèche, Martine Dumont, William Tapper, Sajjad Rafiq, Esther M. John, Alice S. Whittemore, Susan Slager, Drakoulis Yannoukakos, Amanda E. Toland, Song Yao, Wei Zheng, Sandra L. Halverson, Anna González‐Neira, Guillermo Pita, M. Rosario Alonso, Núria Álvarez, Daniel Herrero, Daniel C. Tessier, Daniel Vincent, François Bacot, Craig Luccarini, Caroline Baynes, Shahana Ahmed, Mel Maranian, Catherine S. Healey, Jacques Simard, Per Hall, Douglas F. Easton, Montserrat García‐Closas

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsUniversité LavalUniversité de MontréalMcGill UniversityUniversity Health NetworkUniversity of Toronto
FundersDivision of Cancer Epidemiology and Genetics, National Cancer InstituteMedical Research and Materiel CommandMedical Research CouncilMinistero dello Sviluppo EconomicoAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du TravailRadboud Universitair Medisch CentrumNational Health and Medical Research CouncilOulun YliopistoDeutsche KrebshilfeMedizinischen Hochschule HannoverNorges ForskningsrådUniversitair Medisch Centrum GroningenCenters for Disease Control and PreventionInstitut National Du CancerLeids Universitair Medisch CentrumAssociazione Italiana per la Ricerca sul CancroKWF KankerbestrijdingVetenskapsrådetStockholms Läns LandstingLigue Contre le CancerKuopion Yliopistollinen SairaalaKarolinska InstitutetHerlev HospitalCanadian Institutes of Health ResearchGeneral Secretariat for Research and TechnologySundhed og Sygdom, Det Frie ForskningsrådMinistry of Education and Science of the Russian FederationBundesministerium für Bildung und ForschungMinisterio de Economía y CompetitividadDeutsche Gesetzliche UnfallversicherungNederlandse Organisatie voor Wetenschappelijk OnderzoekRussian Foundation for Basic ResearchMinistère du Développement Économique, de l’Innovation et de l’ExportationLon V. Smith FoundationRadboud UniversiteitUniversiteit LeidenRobert Bosch StiftungFonds Wetenschappelijk OnderzoekCancerfondenNational Cancer InstituteCancer Institute NSWNational Breast Cancer FoundationEuropean CommissionAcademy of FinlandKing's College LondonRoswell Park Cancer InstituteNational Institute for Health and Care ResearchCancer Research UKVrije Universiteit AmsterdamErasmus Universiteit RotterdamMemorial Sloan-Kettering Cancer CenterFondation du cancer du sein du QuébecGenome CanadaItä-Suomen YliopistoAgency for Science, Technology and ResearchDavid F. and Margaret T. Grohne Family FoundationDeutsches KrebsforschungszentrumCancer Council VictoriaCalifornia Department of Public HealthFondation de FranceNIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer ResearchUniversity of CambridgeGovernment of CanadaHelsingin ja Uudenmaan SairaanhoitopiiriVanderbilt UniversityGénome QuébecAgence Nationale de la RechercheU.S. Department of Health and Human ServicesMayo ClinicBreast Cancer Research FoundationSusan G. Komen for the CureU.S. ArmyUniversity of WestminsterCancer Council TasmaniaFrancis Crick InstituteErasmus Medisch CentrumNational Institutes of HealthVanderbilt-Ingram Cancer Center
KeywordsBreast cancerProfiling (computer programming)OncologyComputational biologyInternal medicineMedicineBiologyCancerComputer science

Abstract

fetched live from OpenAlex

BACKGROUND: Data for multiple common susceptibility alleles for breast cancer may be combined to identify women at different levels of breast cancer risk. Such stratification could guide preventive and screening strategies. However, empirical evidence for genetic risk stratification is lacking. METHODS: We investigated the value of using 77 breast cancer-associated single nucleotide polymorphisms (SNPs) for risk stratification, in a study of 33 673 breast cancer cases and 33 381 control women of European origin. We tested all possible pair-wise multiplicative interactions and constructed a 77-SNP polygenic risk score (PRS) for breast cancer overall and by estrogen receptor (ER) status. Absolute risks of breast cancer by PRS were derived from relative risk estimates and UK incidence and mortality rates. RESULTS: There was no strong evidence for departure from a multiplicative model for any SNP pair. Women in the highest 1% of the PRS had a three-fold increased risk of developing breast cancer compared with women in the middle quintile (odds ratio [OR] = 3.36, 95% confidence interval [CI] = 2.95 to 3.83). The ORs for ER-positive and ER-negative disease were 3.73 (95% CI = 3.24 to 4.30) and 2.80 (95% CI = 2.26 to 3.46), respectively. Lifetime risk of breast cancer for women in the lowest and highest quintiles of the PRS were 5.2% and 16.6% for a woman without family history, and 8.6% and 24.4% for a woman with a first-degree family history of breast cancer. CONCLUSIONS: The PRS stratifies breast cancer risk in women both with and without a family history of breast cancer. The observed level of risk discrimination could inform targeted screening and prevention strategies. Further discrimination may be achievable through combining the PRS with lifestyle/environmental factors, although these were not considered in this report.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.304
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations566
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicBRCA gene mutations in cancerFrench-language works237,207